Takeda - Top 10 Layoffs of 2010

Company: Takeda
Layoffs: 1,400

Scoop: As Takeda prepares for diabetes drug Actos' patent expiration, it announced 1,400 jobs cut within the U.S. "The business environment for the pharmaceutical industry is changing dramatically," the company says in a statement, "with the pharmaceutical industry as a whole facing barriers to technological innovation that have halted progress in breakthrough novel drugs, stricter approval processes for new drugs in advanced nations, and radical upheaval in healthcare systems."

The cuts came primarily from Takeda's U.S. headquarters in Deerfield, IL and the Takeda Global Research and Development Center.

Takeda - Top 10 Layoffs of 2010

Suggested Articles

The FDA has granted Amarin's Vascepa a possible blockbuster label expansion for CV risk reduction in patients with or without CV disease.

In a high-stakes patent lawsuit between CAR-T companies Bristol-Myers Squibb and Gilead Sciences, BMS has come up with a victory. 

It’s been a year of ups and downs for Pfizer’s Xeljanz. But the company is hoping to close on a high note, with help from a new extended-release pill.